NLRP3 and glioblastoma: Our results revealed that NLRP3 expression significantly decreased in temozolomide, direct helium, and indirect argon CAP-treated groups compared with the baseline levels in the animal model of glioblastoma, which was in line with the increased survival rate in these groups.